|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500099701 |
|
最近更新日期: Date of Last Refreshed on: |
2025-03-27 11:12:32 |
|
注册时间: Date of Registration: |
2025-03-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于症状管理理论混合现实技术在腰椎间盘突出症恐动症患者中的应用研究 |
|
Public title: |
A study of mixed reality technology based on symptom management theory in patients with lumbar disc herniation agoraphobia |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于症状管理理论混合现实技术在腰椎间盘突出症恐动症患者中的应用研究 |
|
Scientific title: |
A study of mixed reality technology based on symptom management theory in patients with lumbar disc herniation agoraphobia |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
徐华秀 |
研究负责人: |
徐华秀 |
|
Applicant: |
Huaxiu Xu |
Study leader: |
Huaxiu Xu |
|
申请注册联系人电话: Applicant telephone: |
+86 150 8372 9860 |
研究负责人电话: Study leader's telephone: |
+86 150 8372 9860 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
15083729860@163.com |
研究负责人电子邮件: Study leader's E-mail: |
15083729860@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江西省赣州市章贡区青年路23号 |
研究负责人通讯地址: |
江西省赣州市章贡区青年路23号 |
|
Applicant address: |
No. 23, Qingnian Road, Zhanggong District, Ganzhou City, Jiangxi Province |
Study leader's address: |
No. 23, Qingnian Road, Zhanggong District, Ganzhou City, Jiangxi Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
赣南医科大学第一附属医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of Gannan Medical University |
||
|
研究负责人所在单位: |
赣南医科大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Gannan Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
LLSC-2025第105号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
赣南医科大学第一附属医院科学研究伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the First Affiliated Hospital of Gannan Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-03-13 00:00:00 |
||
|
伦理委员会联系人: |
管东霞 |
||
|
Contact Name of the ethic committee: |
Dongxia Guan |
||
|
伦理委员会联系地址: |
江西省赣州市经济技术开发区金岭大道128号 |
||
|
Contact Address of the ethic committee: |
128 Jinling Avenue, Ganzhou Economic and Technological Development Zone, Ganzhou, Jiangxi |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 138 7973 0436 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
赣南医科大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Gannan Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江西省赣州市章贡区青年路23号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 23, Qingnian Road, Zhanggong District, Ganzhou City, Jiangxi Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
江西省赣州市科技局 |
||||||||||||||||||||||
|
Source(s) of funding: |
Ganzhou Science and Technology Bureau, Jiangxi Province |
||||||||||||||||||||||
|
Target disease: |
Lumbar Herniated Disc |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
本研究探讨应用MR技术为LDH恐动症患者制定疼痛数字化训练干预措施的临床应用研究,从患者的疼痛程度、主观症状、临床体征、恐动症、治疗依从性等多维度进行效果评价,旨在降低患者恐动症水平,缓解恐惧、回避心理,促进疼痛自我管理和治疗依从性,改善患者的康复结局。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study investigates the clinical application research of applying MR technology to develop pain digital training interventions for patients with LDH agoraphobia, and evaluates the effects from multiple dimensions such as patients’ pain level, subjective symptoms, clinical signs, agoraphobia, and treatment compliance, aiming to reduce the level of patients’ agoraphobia, alleviate their fear and avoidance, promote pain self-management and treatment compliance, and improve patients’ recovery outcomes. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄>=18岁; 2.经CT或MRI检查符合2020版《腰椎间盘突出症诊疗中国疼痛专家共识》诊断标准,并首次接受行脊柱内镜下腰椎间盘突出髓核摘除术; 3.术后恐动症评分(Tampa scaleof Kinesiophobia,TSK) >37分; 4.术后各项生命体征平稳,意识清楚。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Age>=18 years; 2. Applicants should meet the diagnostic criteria of the 2020 version of the "Chinese Pain Expert Consensus on the Diagnosis and Treatment of Lumbar Intervertebral Disc Herniation" by CT or MRI, and undergo spinal endoscopic lumbar disc herniation nucleus pulposus extraction for the first time; 3. Tampa scale of kinesiophobia (TSK) >37 points; 4. The postoperative vital signs are stable and the consciousness is clear. |
||||||||||||||||||||||
|
排除标准: |
1.伴其他多发骨折、肿瘤、结核等疾病; 2.并存严重心、脑、肝、肾等重要脏器疾病; 3.患有精神疾病及严重认知障碍; 4.术后出现静脉血栓、术区切口感染、脑脊液漏等严重并发症。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Accompanied by other multiple fractures, tumors, tuberculosis and other diseases; 2. Coexisting with serious heart, brain, liver, kidney and other important organ diseases; 3. Suffering from mental illness and severe cognitive impairment; 4. Postoperative venous thrombosis, incision infection in the surgical area, cerebrospinal fluid leakage and other serious complications. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-03-31 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-04-15 00:00:00 至 To 2025-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
纸质表格登记信息、电子表格登记信息 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Paper Form Registration Information, Electronic Form Registration Information |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |